Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,006 | 287 | 98.0% |
| Education | $122.46 | 12 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Electromed, Inc. | $1,215 | 48 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $702.46 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $464.08 | 28 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $382.23 | 20 | $0 (2024) |
| Insmed, Inc. | $345.93 | 19 | $0 (2023) |
| Allergan Inc. | $335.41 | 11 | $0 (2019) |
| Actelion Pharmaceuticals US, Inc. | $326.53 | 16 | $0 (2024) |
| Chiesi USA, Inc. | $261.91 | 16 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $220.67 | 9 | $0 (2024) |
| Mylan Specialty L.P. | $174.46 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $774.96 | 40 | Electromed, Inc. ($164.65) |
| 2023 | $1,115 | 51 | AstraZeneca Pharmaceuticals LP ($257.80) |
| 2022 | $1,121 | 60 | Electromed, Inc. ($225.99) |
| 2021 | $727.24 | 33 | Electromed, Inc. ($270.77) |
| 2020 | $125.00 | 8 | Boehringer Ingelheim Pharmaceuticals, Inc. ($58.80) |
| 2019 | $1,648 | 75 | Electromed, Inc. ($277.79) |
| 2018 | $488.45 | 29 | Allergan Inc. ($94.88) |
| 2017 | $128.03 | 3 | Mallinckrodt LLC ($100.38) |
All Payment Transactions
299 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.39 | General |
| Category: HFCWO | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $21.85 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: Respiratory | ||||||
| 11/06/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: ENDOCRINOLOGY | ||||||
| 10/30/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/24/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: NEUROLOGY | ||||||
| 10/11/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $23.32 | General |
| Category: NEUROLOGY | ||||||
| 10/02/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 10/01/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 09/19/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Immunology | ||||||
| 09/11/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: RESPIRATORY | ||||||
| 08/28/2024 | 3B Medical, Inc. | LUNA (Device) | Food and Beverage | Cash or cash equivalent | $18.97 | General |
| Category: VENTILATOR, NON-CONTINUOUS (RESPIRATOR) | ||||||
| 08/21/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $24.09 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 08/21/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $15.97 | General |
| Category: Airway Clearance Device | ||||||
| 08/20/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $16.16 | General |
| Category: HFCWO | ||||||
| 08/15/2024 | Alcresta Therapeutics, Inc. | RELIZORB (Device) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/15/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: RESPIRATORY | ||||||
| 08/15/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $1.87 | General |
| Category: HFCWO | ||||||
| 08/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: IMMUNOLOGY | ||||||
| 08/05/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $26.73 | General |
| Category: Cardiology | ||||||
| 07/24/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 07/01/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $8.42 | General |
| Category: HFCWO | ||||||
| 06/19/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $11.43 | General |
| Category: HFCWO | ||||||
| 05/29/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $54.55 | General |
| Category: HFCWO | ||||||
| 05/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.80 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,293 | 3,764 | $1.2M | $433,616 |
| 2022 | 25 | 2,445 | 3,884 | $1.2M | $428,913 |
| 2021 | 22 | 2,032 | 3,458 | $1.2M | $414,196 |
| 2020 | 20 | 1,513 | 2,969 | $611,700 | $318,708 |
All Medicare Procedures & Services
102 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 314 | 834 | $275,220 | $140,896 | 51.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 403 | 1,174 | $185,492 | $109,846 | 59.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 105 | 105 | $241,500 | $45,711 | 18.9% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 84 | 87 | $226,200 | $40,209 | 17.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 192 | 278 | $51,430 | $34,541 | 67.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 203 | 252 | $35,280 | $21,035 | 59.6% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 81 | 99 | $17,325 | $8,488 | 49.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 35 | 35 | $9,800 | $5,061 | 51.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 31 | 31 | $7,358 | $4,127 | 56.1% |
| 31645 | Aspiration of initial secretion of lung airway using an endoscope | Facility | 2023 | 34 | 35 | $19,250 | $3,644 | 18.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 46 | $4,628 | $2,880 | 62.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $6,534 | $2,383 | 36.5% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2023 | 31 | 31 | $13,175 | $1,992 | 15.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 32 | 33 | $3,135 | $1,974 | 63.0% |
| G0316 | Prolonged hospital inpatient or observation care evaluation and management service(s) beyond the total time for the primary service (when the primary service has been selected using time on the date of the primary service); each additional 15 minutes by th | Facility | 2023 | 81 | 82 | $9,880 | $1,967 | 19.9% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 13 | 13 | $2,600 | $1,492 | 57.4% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 30 | 30 | $2,400 | $1,190 | 49.6% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 29 | 29 | $2,320 | $1,121 | 48.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 137 | 138 | $17,388 | $1,063 | 6.1% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 143 | 144 | $11,520 | $964.31 | 8.4% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Facility | 2023 | 102 | 102 | $6,630 | $902.52 | 13.6% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 30 | 30 | $3,780 | $792.18 | 21.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 20 | 21 | $1,680 | $496.85 | 29.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 39 | 39 | $3,120 | $362.31 | 11.6% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 45 | 47 | $25,380 | $358.94 | 1.4% |
About Dr. Luis Murillo, MD
Dr. Luis Murillo, MD is a Pulmonary Disease healthcare provider based in Pensacola, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1093938573.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luis Murillo, MD has received a total of $6,128 in payments from pharmaceutical and medical device companies, with $774.96 received in 2024. These payments were reported across 299 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($6,006).
As a Medicare-enrolled provider, Murillo has provided services to 8,283 Medicare beneficiaries, totaling 14,075 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 102 distinct procedure/service records.
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Pulmonary Disease
- Location Pensacola, FL
- Active Since 04/11/2007
- Last Updated 05/31/2018
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1093938573
Products in Payments
- SMARTVEST (Device) $1,215
- AVYCAZ (Drug) $365.41
- OFEV (Drug) $323.93
- TEZSPIRE (Biological) $323.09
- OPSUMIT (Drug) $257.55
- Arikayce (Drug) $253.98
- TRELEGY ELLIPTA (Drug) $253.57
- BRONCHITOL (Drug) $234.71
- XYWAV (Drug) $204.04
- DUPIXENT (Biological) $167.56
- ZENPEP (Drug) $127.83
- NUCALA (Biological) $124.38
- Cayston (Drug) $124.22
- RELIZORB (Device) $121.24
- YUPELRI (Drug) $106.71
- ACTHAR (Biological) $100.38
- SYMBICORT (Drug) $90.26
- FASENRA (Drug) $83.97
- CREON (Drug) $83.04
- Xolair (Biological) $77.98
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Pensacola
Dr. Charles Bryan, M.d, M.D
Pulmonary Disease — Payments: $12,397
Abeer Abutaleb, M.d, M.D
Pulmonary Disease — Payments: $214.78
Dr. Christopher Lewis, M.d, M.D
Pulmonary Disease — Payments: $130.66
Ms. Bijal Patel, Do, DO
Pulmonary Disease — Payments: $103.00
James Stringfield, Md, MD
Pulmonary Disease
Dr. Thomas Williams, M.d, M.D
Pulmonary Disease